BioM Seminar: From Discovery to Clinic: Getting Ready for Phase 1

Today’s scientists are under significant time pressure to accelerate their compound from discovery to the clinic. The seminar will provide insights into the key considerations for a molecule's transition from discovery to Phase 1 readiness, including drug and drug development.

© Shutterstock

The event will take place with the support of Catalent.

The event is fully booked!

Time and Place
Tuesday, May 14, 2019, 9:00 am – 1:30 pm
BioM Biotech Cluster Development GmbH, Am Klopferspitz 19 a (IZB West II, 3. OG), 82152 Martinsried

Today’s scientists are under significant time pressure to accelerate their compound from discovery to the clinic. Such pressure can often lead research organizations to adopt short-term thinking and overlook the downstream realities of drug development. Addressing issues early and comprehensively in the development life-cycle can result in fewer problems down the line such as escalating timelines, costs and regulatory issues. It is important to leverage the skills and experience of experts and connect the dots between competencies to optimize the development pathway and enable drug candidates to reach their true potential.

Main Topics

  • Developability assessment: Can your molecule become a drug?
  • Integrating PK modelling and in vivo studies for improved formulation and dosage form development
  • Formulation selection
  • Considerations prior to performing a Phase 0 or Phase I clinical trial
  • Efficient coordination of clinical supplies

You will gain insight into key considerations for transitioning a molecule from discovery to phase 1 readiness including active pharmaceutical ingredient and drug product development.

The detailed agenda for the BioM seminar "From Discovery to Clinic: Getting Ready for Phase 1" can be downloaded (pdf).

Target Group
This seminar is intended for scientists in either industry or academia who are working in the field of drug discovery and want to bring the candidates successfully into Phase 1.

Dr. Daniela Woide
, Director Sales and Marketing, ProJect Pharmaceutics GmbH
Dr. William Chin
, Technical Specialist, Science & Technology, Catalent
Dr. Guillaume Enderlin, Product Development Supervisor, Catalent
Dr. Jan Neelissen, Scientific Adviser For PK/PD Modeling, Science & Technology, Catalent
Anders Millerhovf, CEO, Clinial Trial Consultants AB
Sascha Sonnenberg, VP Cell&Gene and CTS Services, Marken


Gabriele Klingner
BioM Biotech Cluster Development GmbH
Phone.: +49 (0) 89-899679-15

The event is free, but a registration is necessary.